← Back to Search

Artificial Intelligence

FUSION closed loop glucose control system for Type 2 Diabetes

N/A
Recruiting
Led By Francisco Pasquel, MD
Research Sponsored by Ideal Medical Technologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time frame: from beginning of use of the fusion system to end of use of the fusion system, which will be a period of time of up to 24 hours
Awards & highlights

Study Summary

This trial will test an AI-powered system that uses 3 meals to keep a diabetic's glucose levels between 100-140 mg/dL for 24 hours.

Eligible Conditions
  • Type 2 Diabetes
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time frame: from beginning of use of the fusion system to end of use of the fusion system, which will be a period of time of up to 24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: from beginning of use of the fusion system to end of use of the fusion system, which will be a period of time of up to 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Efficacy Outcome
Primary Safety Outcome
Secondary outcome measures
Glucose Dispersion
Hyperglycemia
Percent Time in the Desired Control Range
+1 more
Other outcome measures
Average glucose value used by FUSION system versus from blood
Glucose readings from CGM's versus from blood

Trial Design

1Treatment groups
Experimental Treatment
Group I: FUSION closed loop glucose control systemExperimental Treatment1 Intervention
All subjects will be treated with the FUSION closed loop glucose control system for up to 24 hours

Find a Location

Who is running the clinical trial?

Emory UniversityOTHER
1,638 Previous Clinical Trials
2,560,524 Total Patients Enrolled
Ideal Medical TechnologiesLead Sponsor
1 Previous Clinical Trials
2 Total Patients Enrolled
Leon DeJournett, MDStudy DirectorIdeal Medical Technologies
1 Previous Clinical Trials
2 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Will elderly individuals over the age of 70 be eligible to partake in this research?

"The eligibility criteria for this medical trial requires that patients must be of 18 years or above and below 70."

Answered by AI

For whom is this medical trial available?

"This clinical study is accepting 8 individuals who have diabetes and an autoimmune condition, between 18 to 70 years old."

Answered by AI

Are there any available opportunities for participation in this clinical trial?

"According to clinicaltrials.gov, this research trial is actively searching for volunteers and has been since November 8th 2022; the most recent update was posted on November 30th of that same year."

Answered by AI

What is the scope of this research in terms of participant participation?

"Yes, the data hosted on clinicaltrials.gov verifies that this medical study is actively recruiting patients. It was initially posted in November 8th 2022 and subsequently updated at the end of the same month. The trial requires 8 participants from a single centre to complete it."

Answered by AI

What should this trial aim to illustrate?

"The main purpose of this investigation, which will span up to 24 hours from the start of using FUSION until its conclusion, is to assess the Primary Efficacy Outcome. Secondary objectives include evaluating Hyperglycemia (glucose values above 180 mg/dL), Percent Time in Desired Control Range (100-140 mg/dL.), and Severe Hypoglycemia (values below 54 mg/dL)."

Answered by AI

Who else is applying?

What state do they live in?
Georgia
North Carolina
What site did they apply to?
Emory University
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

Looking for solutions to glucose level fluctuations.
PatientReceived 2+ prior treatments

What questions have other patients asked about this trial?

Screening visits time line and frequency?
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes
2022. "Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05644730.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top